{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:18:57Z","timestamp":1787318337338,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771722"],"award-info":[{"award-number":["81771722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2021SK2032"],"award-info":[{"award-number":["2021SK2032"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Liver fibrosis is thought to have a  close relationship with lipid profile. The possible association between lipids and liver fibrosis of different etiologies has been widely explored. However, the association between lipids and liver fibrosis in patients infected with\n                      <jats:italic>Schistosoma japonicum<\/jats:italic>\n                      remains unclear. In the present study we undertook a preliminary exploration of the association between lipid profile and liver fibrosis, and developed a new predictive index for liver fibrosis in\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      -infected patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 1503 patients diagnosed with\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      at Xiangyue Hospital, China were enrolled in this retrospective study. The patients were divided into two groups, i.e., those with and those  without liver fibrosis, by two experienced schistosomiasis specialists, according to the results of liver ultrasound examination. Demographic, clinical, and laboratory data were collected. Multivariable logistic models were used to estimate the independent associations between lipid profile and liver fibrosis. Receiver operating characteristic (ROC) curves were used to assess the discriminative ability of the new index in predicting liver fibrosis in patients with schistosomiasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Logistic regression analysis showed that high-density lipoprotein (HDL) [adjusted odds ratio (aOR), 95% confidence interval (CI) 7.334, 5.051\u201310.649;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001], low-density lipoprotein (LDL) (aOR, 95% CI 0.434, 0.370\u20130.509;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), hemoglobin (HB) (aOR, 95% CI 0.979, 0.971\u20130.987;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and platelets (PLT) (aOR, 95% CI 0.996, 0.994\u20130.999;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) were independently associated with liver fibrosis in patients with schistosomiasis. ROC analysis indicated that the combination of HDL, LDL and HB levels [(HDL\u00a0\u00d7\u00a0100)\/(LDL\u00a0\u00d7\u00a0HB)] had a higher area under the ROC curve (AUC\u2009=\u20090.773), and thus may better predict liver fibrosis than the aspartate transaminase-to-platelet ratio index (AUC\u2009=\u20090.608) and fibrosis index based on four factors (AUC\u2009=\u20090.624).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To the best of our knowledge, this is the first study to report that HDL, LDL, HB and PLT levels are independently associated with liver fibrosis in patients with schistosomiasis. (HDL\u00a0\u00d7\u00a0100)\/(LDL\u00a0\u00d7\u00a0HB) outperformed the aspartate transaminase-to-platelet ratio index and fibrosis index based on four factors in terms of ROC, and thus could be a new predictive index for liver fibrosis. These findings may help clinicians to more easily and effectively diagnose liver fibrosis in patients with schistosomiasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-022-05359-8","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:04:48Z","timestamp":1659078288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between serum lipid profile and liver fibrosis in patients infected with Schistosoma japonicum"],"prefix":"10.1186","volume":"15","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PengPeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunHui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YingZi","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"5359_CR1","unstructured":"World Health Organization. Schistosomiasis. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 2 July 2021."},{"key":"5359_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou X-N. Schistosomiasis. Nat Rev Dis Prim. 2018;4:13.","journal-title":"Nat Rev Dis Prim"},{"key":"5359_CR3","first-page":"611","volume":"28","author":"L Zhang","year":"2016","unstructured":"Zhang L, Zhimin XU, Qian Y, Dang H, Shan LV, Jing XU, et al. Endemic status of schistosomiasis in People\u2019s Republic of China in 2015. Chin J Schistosomiasis Control. 2016;28:611\u20137.","journal-title":"Chin J Schistosomiasis Control"},{"key":"5359_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.actatropica.2005.07.005","volume":"96","author":"X-N Zhou","year":"2005","unstructured":"Zhou X-N, Wang L-Y, Chen M-G, Wu X-H, Jiang Q-W, Chen X-Y, et al. The public health significance and control of schistosomiasis in China\u2014then and now. Acta Trop. 2005;96:97\u2013105.","journal-title":"Acta Trop"},{"key":"5359_CR5","first-page":"576","volume":"31","author":"LJ Zhang","year":"2019","unstructured":"Zhang LJ, Xu ZM, Guo JY, Dai SM, Dang H, L\u00fc S, et al. Endemic status of schistosomiasis in People\u2019s Republic of China in 2018. (Zhongguo xue xi chong bing fang zhi za zhi). J Schistosomiasis Control. 2019;31:576\u201382.","journal-title":"J Schistosomiasis Control"},{"key":"5359_CR6","doi-asserted-by":"crossref","first-page":"e02582","DOI":"10.1128\/AAC.02582-16","volume":"61","author":"N Vale","year":"2017","unstructured":"Vale N, Gouveia MJ, Rinaldi G, Brindley PJ, G\u00e4rtner F, da CorreiaCosta JM. Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance. Antimicrob Agents Chemother. 2017;61:e02582-16.","journal-title":"Antimicrob Agents Chemother."},{"key":"5359_CR7","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1007\/s00436-015-4616-7","volume":"114","author":"H Hua","year":"2015","unstructured":"Hua H, Yin A, Xu M, Zhou Z, You L, Guo H. Advanced schistosomiasis reappeared after seemingly being cured for over 20 years and without known history of reexposure to Schistosoma japonicum. Parasitol Res. 2015;114:3535\u20138.","journal-title":"Parasitol Res"},{"key":"5359_CR8","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","volume":"9","author":"SD Kamdem","year":"2018","unstructured":"Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK. Host regulators of liver fibrosis during human schistosomiasis. Front Immunol. 2018;9:2781.","journal-title":"Front Immunol"},{"key":"5359_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fimmu.2013.00089","volume":"4","author":"E Hams","year":"2013","unstructured":"Hams E, Aviello G, Fallon PG. The schistosoma granuloma: friend or foe? Front Immunol. 2013;4:89.","journal-title":"Front Immunol"},{"key":"5359_CR10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-3024.2009.01157.x","volume":"31","author":"ZA Andrade","year":"2009","unstructured":"Andrade ZA. Schistosomiasis and liver fibrosis: review article. Parasite Immunol. 2009;31:656\u201363.","journal-title":"Parasite Immunol"},{"key":"5359_CR11","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3389\/fimmu.2018.02295","volume":"9","author":"JK Nono","year":"2018","unstructured":"Nono JK, Kamdem SD, Netongo PM, Dabee S, Schomaker M, Oumarou A, et al. Schistosomiasis burden and its association with lower measles vaccine responses in school children from rural Cameroon. Front Immunol. 2018;9:2295.","journal-title":"Front Immunol"},{"key":"5359_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/588826","volume":"198","author":"V Arnaud","year":"2008","unstructured":"Arnaud V, Li J, Wang Y, Fu X, Mengzhi S, Luo X, et al. Regulatory role of interleukin-10 and interferon-\u03b3 in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum. J Infect Dis. 2008;198:418\u201326.","journal-title":"J Infect Dis"},{"key":"5359_CR13","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1084\/jem.20090383","volume":"206","author":"A Dessein","year":"2009","unstructured":"Dessein A, Chevillard C, Arnaud V, Hou X, Hamdoun AA, Dessein H, et al. Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes CTGF and severe hepatic fibrosis. J Exp Med. 2009;206:2321\u20138.","journal-title":"J Exp Med"},{"key":"5359_CR14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ccr.2010.01.022","volume":"17","author":"HA Hirsch","year":"2010","unstructured":"Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, Bulyk M, et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell. 2010;17:348\u201361.","journal-title":"Cancer Cell"},{"key":"5359_CR15","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99-112.","journal-title":"Hepatology"},{"key":"5359_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jgh.12432","volume":"29","author":"\u00c1 Mena","year":"2014","unstructured":"Mena \u00c1, Pedreira JD, Castro \u00c1, L\u00f3pez S, V\u00e1zquez P, Poveda E. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol. 2014;29:173\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"5359_CR17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/MEG.0000000000001461","volume":"31","author":"RF Jaafar","year":"2019","unstructured":"Jaafar RF, Hajj Ali AM, Zaghal AM, Kanso M, Habib SG, Halaoui AF, et al. Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2019;31:1540\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5359_CR18","doi-asserted-by":"crossref","unstructured":"Wu X, Zhang B, Liu J, Xu L, Song L, Zhou Y, et al. Lipid Metabolism Regulate the Inflammatory Microenvironment in the Hepatic Fibrosis Induced by Schistosoma Japonicum Infection in China. A Genotype-Phenotype Association Study. 2018. Preprint at http:\/\/doi.org\/10.2139\/ssrn.3284187.","DOI":"10.2139\/ssrn.3284187"},{"key":"5359_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-4-1","volume":"4","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Zheng H, Jiang Q. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control. Parasit Vectors. 2011;4:1\u20137.","journal-title":"Parasit Vectors"},{"key":"5359_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0001-706X(92)90020-X","volume":"51","author":"Group CW","year":"1992","unstructured":"Group CW. The use of diagnostic ultrasound in schistosomiasis\u2014attempts at standardization of methodology. Acta Trop. 1992;51:45\u201363.","journal-title":"Acta Trop"},{"key":"5359_CR21","volume-title":"Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity: Second International Workshop, October 22\u201326 1996, Niamey","author":"J Richter","year":"2000","unstructured":"Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM. Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity: Second International Workshop, October 22\u201326 1996, Niamey. Niger: World Health Organization; 2000."},{"key":"5359_CR22","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u201326.","journal-title":"Hepatology"},{"key":"5359_CR23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"5359_CR24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jgh.14595","volume":"34","author":"H Fujii","year":"2019","unstructured":"Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, et al. HOMA-IR: an independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2019;34:1390\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"5359_CR25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.23736\/S0026-4806.19.05978-0","volume":"110","author":"A Klisic","year":"2019","unstructured":"Klisic A, Abenavoli L, Fagoonee S, Kavaric N, Kocic G, Nini\u0107 A. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. Minerva Med. 2019;110:191\u20138.","journal-title":"Minerva Med"},{"key":"5359_CR26","first-page":"3017","volume":"36","author":"AM Fogelman","year":"2015","unstructured":"Fogelman AM. Further evidence that high-density lipoprotein is a chameleon-like lipoprotein. Eur Heart J. 2015;36:3017\u20139.","journal-title":"Eur Heart J"},{"key":"5359_CR27","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1194\/jlr.R800097-JLR200","volume":"50","author":"JW Heinecke","year":"2009","unstructured":"Heinecke JW. The HDL proteome: a marker\u2013and perhaps mediator\u2013of coronary artery disease. J Lipid Res. 2009;50:S167\u201371.","journal-title":"J Lipid Res"},{"key":"5359_CR28","volume":"9","author":"CSM da Fonseca","year":"2014","unstructured":"da Fonseca CSM, Pimenta Filho AA, dos Santos BS, da Silva CA, Domingues ALC, Owen JS, et al. Human plasma lipid modulation in Schistosomiasis mansoni depends on apolipoprotein E polymorphism. PLoS ONE. 2014;9:e101964.","journal-title":"PLoS ONE"},{"key":"5359_CR29","doi-asserted-by":"crossref","first-page":"645807","DOI":"10.3389\/fvets.2021.645807","volume":"8","author":"X Yang","year":"2021","unstructured":"Yang X, Ding W, Qian X, Jiang P, Chen Q, Zhang X, et al. Schistosoma japonicum infection leads to the reprogramming of glucose and lipid metabolism in the colon of mice. Front Vet Sci. 2021;8:645807.","journal-title":"Front Vet Sci"},{"key":"5359_CR30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10753-019-01160-5","volume":"43","author":"X Qian","year":"2020","unstructured":"Qian X, Ding W, Chen Q, Zhang X, Jiang W, Sun F, et al. The metabolic reprogramming profiles in the liver fibrosis of mice infected with Schistosoma japonicum. Inflammation. 2020;43:731\u201343.","journal-title":"Inflammation"},{"key":"5359_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008464","volume":"14","author":"JF Zinsou","year":"2020","unstructured":"Zinsou JF, Janse JJ, Honpkehedji YY, Dejon-Agob\u00e9 JC, Garc\u00eda-Tard\u00f3n N, Hoekstra PT, et al. Schistosoma haematobium infection is associated with lower serum cholesterol levels and improved lipid profile in overweight\/obese individuals. PLoS Negl Trop Dis. 2020;14:e0008464.","journal-title":"PLoS Negl Trop Dis"},{"key":"5359_CR32","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/28609.10459","author":"I Valkov","year":"2017","unstructured":"Valkov I, Ivanova R, Alexiev A, Antonov K, Mateva L. Association of serum lipids with hepatic steatosis, stage of liver fibrosis and viral load in chronic hepatitis C. J Clin Diagnostic Res. 2017. https:\/\/doi.org\/10.7860\/JCDR\/2017\/28609.10459.","journal-title":"J Clin Diagnostic Res"},{"key":"5359_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.11.038","author":"M Israelsen","year":"2020","unstructured":"Israelsen M, Juel HB, Detlefsen S, Madsen BS, Rasmussen DN, Larsen TR, et al. Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2020.11.038.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5359_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91\u2013100.","journal-title":"Gastroenterology"},{"key":"5359_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.16.337592","author":"L Niu","year":"2020","unstructured":"Niu L, Thiele M, Geyer PE, Rasmussen DN, Webel HE, Santos A, et al. A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver disease. BioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.10.16.337592.","journal-title":"BioRxiv"},{"key":"5359_CR36","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.22565","volume":"48","author":"W Qiu","year":"2008","unstructured":"Qiu W, Federico L, Naples M, Avramoglu RK, Meshkani R, Zhang J, et al. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B\u2013containing lipoproteins. Hepatology. 2008;48:1799\u2013809.","journal-title":"Hepatology"},{"key":"5359_CR37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1590\/S0004-28032014000100008","volume":"51","author":"TB Medeiros","year":"2014","unstructured":"Medeiros TB, Domingues ALC, Luna CF, Lopes EP. Correlation between platelet count and both liver fibrosis and spleen diameter in patients with Schistosomiasis mansoni. Arq Gastroenterol. 2014;51:34\u20138.","journal-title":"Arq Gastroenterol"},{"key":"5359_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/s0004-2803.2017v54n1-10","volume":"54","author":"AVMS Barreto","year":"2017","unstructured":"Barreto AVMS, Alecrim VM, de Medeiros TB, Domingues ALC, Lopes EP, Martins JRM, et al. New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni. Arq Gastroenterol. 2017;54:51\u20136.","journal-title":"Arq Gastroenterol"},{"key":"5359_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.parint.2013.02.005","volume":"62","author":"Y Wu","year":"2013","unstructured":"Wu Y, Xu N, Hu J, Xu X, Wu W, Gao S, et al. A simple noninvasive index to predict significant liver fibrosis in patients with advanced Schistosomiasis japonica. Parasitol Int. 2013;62:283\u20138.","journal-title":"Parasitol Int"},{"key":"5359_CR40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/430929","volume":"192","author":"HM Coutinho","year":"2005","unstructured":"Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, Leenstra T, et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum\u2013associated hepatic fibrosis, in Leyte. Philipp J Infect Dis. 2005;192:528\u201336.","journal-title":"Philipp J Infect Dis"},{"key":"5359_CR41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","volume":"58","author":"MV Machado","year":"2013","unstructured":"Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. Crit Apprais J Hepatol. 2013;58:1007\u201319.","journal-title":"Crit Apprais J Hepatol"},{"key":"5359_CR42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jvh.12279","volume":"21","author":"E Teshale","year":"2014","unstructured":"Teshale E, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, et al. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the chronic hepatitis cohort study (CHeCS). J Viral Hepat. 2014;21:917\u201320.","journal-title":"J Viral Hepat"},{"key":"5359_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/357287","author":"HI Fallatah","year":"2014","unstructured":"Fallatah HI. Noninvasive biomarkers of liver fibrosis: an overview. Adv Hepatol. 2014. https:\/\/doi.org\/10.1155\/2014\/357287.","journal-title":"Adv Hepatol"},{"key":"5359_CR44","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"Z Lin","year":"2011","unstructured":"Lin Z, Xin Y, Dong Q, Wang Q, Jiang X, Zhan S, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726\u201336.","journal-title":"Hepatology"},{"key":"5359_CR45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.parint.2018.01.004","volume":"67","author":"S Wu","year":"2018","unstructured":"Wu S, Tseng Y, Xu N, Yin X, Xie X, Zhang L, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with advanced Schistosomiasis mansoni. Parasitol Int. 2018;67:302\u20138.","journal-title":"Parasitol Int"},{"key":"5359_CR46","first-page":"163","volume":"28","author":"YM Wu","year":"2020","unstructured":"Wu YM, Yin XG, Zhang LF, Zhou LY. Comparison between transient elastography and noninvasive diagnostic model for the evaluation of liver fibrosis in patients with liver disease of Schistosoma japonicum. Chin J Hepatol (Zhonghua Gan Zang Bing Za Zhi). 2020;28:163\u20137.","journal-title":"Chin J Hepatol (Zhonghua Gan Zang Bing Za Zhi)"},{"key":"5359_CR47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ijpara.2017.05.007","volume":"47","author":"S Cabantous","year":"2017","unstructured":"Cabantous S, Hou X, Louis L, He H, Mariani O, Sastre X, et al. Evidence for an important role of host microRNAs in regulating hepatic fibrosis in humans infected with Schistosoma japonicum. Int J Parasitol. 2017;47:823\u201330.","journal-title":"Int J Parasitol"},{"key":"5359_CR48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1590\/0037-8682-0113-2018","volume":"51","author":"FLD Silva","year":"2018","unstructured":"Silva FLD, Del-Rei RP, Fraga DBM, Leony LM, Souza AMGCD, Santos FLN. Alterations in the lipid profiles and circulating liver enzymes in individuals infected by Schistosoma mansoni. Rev Soc Bras Med Trop. 2018;51:795\u2013801.","journal-title":"Rev Soc Bras Med Trop"}],"updated-by":[{"DOI":"10.1186\/s13071-022-05470-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000}}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05359-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T09:38:41Z","timestamp":1664962721000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5359"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05359-8","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13071-022-05470-w","URL":"https:\/\/doi.org\/10.1186\/s13071-022-05470-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the IRB of the Third Xiangya Hospital, Central South University. In accordance with IRB requirements for retrospective studies, no consent form was needed for the patient medical records review and data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}